| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lymphoma, Large-Cell, Immunoblastic | |||||
| Lymphoma, Non-Hodgkin | |||||
| 3 | More general conditions related to this trial | ||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoma | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| liposomal amphotericin B | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Abelcet | |||||
| AmBisome | |||||
| Amphotericin B | |||||
| 6 | More general drug interventions related to this trial | ||||
| Amebicides | |||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Antibiotics, Antifungal | |||||
| Antifungal Agents | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| European Organization for Research and Treatment of Cancer | |||||
|
